We talked about the risks associated with human error in high-security research labs, emphasizing the need for appropriate regulation and oversight. Shifting to bone health, I described a new technique called "microindentation" that measures bone resilience, a good measure of the health of bones. Good bone health is crucial for preventing fractures, especially in older adults. Lastly, we covered a promising pineapple-flavored under-the-tongue spray vaccine to prevent recurrent urinary tract infections. It has shown significant efficacy in trials but faces regulatory hurdles in the US despite having been approved in other countries.
You can listen to my conversation with Mark Hahn here
You can find my article on bone health here
You can find my article on the vaccine to prevent chronic urinary tract infections here
Henry I. Miller, MS, MD
Henry I. Miller, MS, MD, is the Glenn Swogger Distinguished Fellow at the American Council on Science and Health. His research focuses on public policy toward science, technology, and medicine, encompassing a number of areas, including pharmaceutical development, genetic engineering, models for regulatory reform, precision medicine, and the emergence of new viral diseases. Dr. Miller served for fifteen years at the US Food and Drug Administration (FDA) in a number of posts, including as the founding director of the Office of Biotechnology.
